Innovative Medicines for Luxembourg (IML) is the national association representing research-based pharmaceutical companies active in Luxembourg. IML promotes timely and sustainable access to innovative medicines, supports a competitive life-sciences environment, and serves as a structured partner for public authorities, healthcare stakeholders and patient organisations on pharmaceutical policy, public health, market access and European healthcare initiatives.
